Financial News
Latest News about MRK
Recent news which mentions MRK
Oncorus, Gaeta Therapeutics Ink Cancer Candidate Licensing Agreement
November 11, 2021
From Benzinga
This Company Says It's One Step Closer to Transforming Cancer Treatment with its Latest Groundbreaking Immunotherapy
November 11, 2021
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
3 Vaccine Stocks With Big Opportunities Outside of COVID-19
November 11, 2021
From Motley Fool
From InvestorPlace
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
From Benzinga
Could Pfizer's COVID Pill Be Even Bigger Than Its Vaccine?
November 10, 2021
From Motley Fool
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
November 09, 2021
From Benzinga
Pfizer and BioNTech to seek backing for COVID-19 booster in all U.S. adults aged 18 and over, as deaths still average 1,200 a day
November 09, 2021
From MarketWatch
US Government To Purchase Additional 1.4M Doses Of Merck's COVID-19 Pill
November 09, 2021
Tickers
MRK
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
From Benzinga
Better COVID Stock: Merck vs. Pfizer
November 09, 2021
From Motley Fool
From Benzinga
3 Dow Stocks That Are Screaming Buys in November
November 09, 2021
From Motley Fool
Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News?
November 09, 2021
From Motley Fool
Merck Ahead Of Pfizer In Talks With Europe For COVID-19 Pills: Reuters
November 08, 2021
From Benzinga
Caterpillar, Fluor, and ChargePoint Among Companies That Could Benefit from Infrastructure Bill
November 08, 2021
From Benzinga
Why BioNTech Stock Is Bouncing Back Today
November 08, 2021
From Motley Fool
Are Vaccine Stocks A Buy On Earnings?
November 08, 2021
From InvestorPlace
Why Moderna Stock Faltered In October
November 08, 2021
From Motley Fool
Here's Why Merck Stock Vaulted Higher in October
November 08, 2021
From Motley Fool
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
3 Best Biotech Stocks to Buy in November
November 08, 2021
From Motley Fool
Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?
November 06, 2021
From Motley Fool
Will Pfizer Outgun Merck With Oral COVID-19 Pill?
November 05, 2021
From Benzinga
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
Why Vir Biotechnology Stock Is Sliding Today
November 05, 2021
From Motley Fool
Dow Jones Gains 300 Points on Jobs Report, Merck Shares Slammed on Pfizer's COVID Pill Results
November 05, 2021
From Motley Fool
Why BioNTech Stock Is Plunging Today
November 05, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
